ES2133727T3 - Derivados de acido hidroxamico como inhibidores de metaloproteinasa. - Google Patents

Derivados de acido hidroxamico como inhibidores de metaloproteinasa.

Info

Publication number
ES2133727T3
ES2133727T3 ES95906402T ES95906402T ES2133727T3 ES 2133727 T3 ES2133727 T3 ES 2133727T3 ES 95906402 T ES95906402 T ES 95906402T ES 95906402 T ES95906402 T ES 95906402T ES 2133727 T3 ES2133727 T3 ES 2133727T3
Authority
ES
Spain
Prior art keywords
acid derivatives
hydroxamic acid
propilcarbamoil
dimetil
hidroxi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95906402T
Other languages
English (en)
Inventor
Raymond Paul Beckett
Mark Whittaker
Andrew Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2133727T3 publication Critical patent/ES2133727T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LOS SIGUIENTES COMPUESTOS: ACIDO 2S-HIDROXI-3R-[1S-(TERTBUTILCARBAMOIL)-2,2-DIMETIL-PROPILCARBAMOIL]-5-METILHEXANOHIDROXAMICO, ACIDO 2S-HIDROXI-3R-[1S-(N,NDIMETILCARBAMOIL)-2,2-DIMETIL-PROPILCARBAMOIL]-5-METILHEXANOHIDROXAMICO, ACIDO 2S-HIDROXI-3R-[1S-(3-HIDROXI-2,2DIMETILPROPILCARBAMOIL)-2,2-DIMETIL-PROPILCARBAMOIL]-5-METILHEXANOHIDROXAMICO, ACIDO 2S-HIDROXI-3R-[1S-(METILCARBAMOIL)-2,2DIMETIL-PROPILCARBAMOIL]-6-FENIL-HEXANOHIDROXAMICO Y ACIDO 2SHIDROXI-3R-[1S-(METILCARBAMOIL)-2,2-DIMETIL-BUTILCARBAMOIL]-5METIL-HEXANOHIDROXAMICO SON INHIBIDORES DE METALOPROTEINASA MATRIZ.
ES95906402T 1994-01-21 1995-01-23 Derivados de acido hidroxamico como inhibidores de metaloproteinasa. Expired - Lifetime ES2133727T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9401129A GB9401129D0 (en) 1994-01-21 1994-01-21 Hydroxamic acid derivatives as metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
ES2133727T3 true ES2133727T3 (es) 1999-09-16

Family

ID=10749121

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95906402T Expired - Lifetime ES2133727T3 (es) 1994-01-21 1995-01-23 Derivados de acido hidroxamico como inhibidores de metaloproteinasa.

Country Status (7)

Country Link
US (1) US5861436A (es)
EP (1) EP0740653B1 (es)
JP (1) JPH09508115A (es)
DE (1) DE69511240T2 (es)
ES (1) ES2133727T3 (es)
GB (1) GB9401129D0 (es)
WO (1) WO1995019957A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU678884B2 (en) * 1994-01-22 1997-06-12 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
GB9601042D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Medical use
NZ322553A (en) 1995-11-23 1998-12-23 British Biotech Pharm Metalloproteinase inhibitors
US7608262B2 (en) 1996-02-16 2009-10-27 The Kennedy Institute Of Rheumatology Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
JP4238334B2 (ja) 1996-09-10 2009-03-18 ヴァーナリス （アールアンドディー） リミテッド 細胞増殖抑制性ヒドロキサム酸誘導体
EP0897908A1 (de) 1997-08-19 1999-02-24 Roche Diagnostics GmbH 3-Aryl-Succinamido-Hydroxamsäuren, Prozesse zu ihrer Herstellung und diese Substanzen enthaltende Medikamente
KR100589474B1 (ko) * 1998-03-26 2006-06-14 산텐 세이야꾸 가부시키가이샤 신규한 우레아 유도체
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
WO2000007985A1 (en) 1998-08-05 2000-02-17 Santen Pharmaceutical Co., Ltd. Novel urea derivatives bearing nitrogenous aromatic heterocycles
EP1143941A3 (de) * 1999-01-13 2002-02-06 Jomaa Pharmaka GmbH Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen
GB9901863D0 (en) * 1999-01-29 1999-03-17 British Biotech Pharm Antibacterial agents
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
RU2245876C2 (ru) * 2000-03-21 2005-02-10 Дзе Проктер Энд Гэмбл Компани Производные сульфонамидов и фармацевтическая композиция на их основе
CA2401728A1 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
WO2001070682A2 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
ES2353020T3 (es) 2000-05-31 2011-02-24 Santen Pharmaceutical Co., Ltd. (piridinil)alquil-amidas o -ureas como inhibidores de la producción del tnf-alfa.
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
AU2003300379A1 (en) * 2002-12-27 2004-07-29 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collagen and MMPI
WO2004060346A2 (en) 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
JP2006517960A (ja) * 2003-02-18 2006-08-03 ファイザー インコーポレイテッド Ｃ型肝炎ウイルスの阻害剤、それを使用する組成物および治療法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122359C (es) * 1964-03-06
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
US5183900A (en) * 1990-11-21 1993-02-02 Galardy Richard E Matrix metalloprotease inhibitors
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
GB9102635D0 (en) * 1991-02-07 1991-03-27 British Bio Technology Compounds
AU666727B2 (en) * 1992-06-25 1996-02-22 F. Hoffmann-La Roche Ag Hydroxamic acid derivatives
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
US5310121A (en) * 1992-07-24 1994-05-10 Consilium Bulk Babcock Atlanta, Inc. Cold weather bulk stacker/reclaimer apparatus and method
AU678884B2 (en) * 1994-01-22 1997-06-12 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors

Also Published As

Publication number Publication date
EP0740653A1 (en) 1996-11-06
DE69511240D1 (de) 1999-09-09
DE69511240T2 (de) 1999-12-09
JPH09508115A (ja) 1997-08-19
US5861436A (en) 1999-01-19
WO1995019957A1 (en) 1995-07-27
GB9401129D0 (en) 1994-03-16
EP0740653B1 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
FI923275A7 (fi) Entsyymi, jolla on sellulaasiaktiivisuutta
FI963219L (fi) Mykofenolihapon 4-aminojohdannaiset, joilla on immunosuppressanttiaktiivisuutta
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
FI973018A7 (fi) Tehokkaan absorbentin omaava substraatti, menetelmä sen valmistamiseks i sekä sen käyttö
MX9205678A (es) Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa.
PT888359E (pt) Derivados de pirimidin-4-ona como pesticida
FI963462L (fi) Bentsotiofeeni-, bentsofuraani- ja indolitiatsepinonit, -oksatsepinonit ja -diatsepinonit soluadheesion estäjinä ja HIV:n estäjinä
IE820084L (en) Azabicyclohexanones.
FI841448L (fi) Anordning foer upprullning av en materialbana, speciellt en pappersbana, pao en hylsa.
DE3679793D1 (de) 5-amino- und 5-hydroxy-6,8-difluorchinolone als antibakterielle wirkstoffe.
NL191314C (nl) 3-Monogesubstitueerd-1-azetidine-carboxamidederivaat, alsmede een anticonvulsief preparaat.
DE69626754D1 (de) Wässrige, vernetzbare Zusammensetzungen
PT1104762E (pt) Imidazo¬1,2a|azinas substituidas como inibidoras selectivas de cox 2
FI811313A7 (fi) Erittäin vaikuttava polyoleffiini katalyyttikomponentti ja menetelmä sen valmistamiseksi sekä valmistetukomponentin käyttö.
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
ID16192A (id) Proses pembuatan asam-asam .alpha., beta-karboksilat organik tak jenuh
DE69735479D1 (de) Metalloproteinase inhibitoren
FI860033A0 (fi) Anordning foer faestande av platta isolermaterial, i synnerhet vaermeisoleringsmattor eller -papp, pao tunnvaeggiga underlag, saosom plaoten i ventilationskanaler.
FI863724A7 (fi) Uusia dispergoituvia, aktiivisia liimakoostumuksia.
NL7810700A (nl) Ureumderivaten, de bereidingswijze en toepassing daarvan.
FI864863A0 (fi) Foerfarande foer lastning av styckegods pao lastpallar i ett lastutrymme, saerskilt ett fartygs lastrum.
FI854708A7 (fi) Orgaaninen yhdiste, mikrobiologinen menetelmä sen valmistamiseksi samoin kuin sen käyttö.
EE200000179A (et) 1-oxa, aza ja tianaftaleen-2-1 biseetrid fosfolambaani inhibiitoritena

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 740653

Country of ref document: ES